Resources

Type of publications
Regions
Diseases
5052 results found
2025 ∙ Williams, L. R. Hombach, J. Marti, M.
Evaluating the Immunogenicity, Efficacy, and Effectiveness of Recombinant Zoster Vaccine for Global Public Health Policy
All age groups Herpes zoster Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Zadeh Mehrizi, T. Eshrati, B. Ebrahimi Shahmabadi, H.
Evaluation of recent pre-booster studies on hepatitis B vaccine effectiveness across WHO regions with HBV prevalence above 1% in the general population up to 60 years of age: a systematic review
All age groups Hepatitis B Efficacy/effectiveness Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Sterian, M. Naganathan, T. Corrin, T. Waddell, L.
Evidence on the associations and safety of COVID-19 vaccination and post COVID-19 condition: An updated living systematic review
All age groups COVID-19 Efficacy/effectiveness Safety Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Larson, A. Shanmugam, P. Mitrovich, R. Vohra, D. Lansdale, A. J. Eiden, A. L.
Expanding vaccination provider types and administration sites can increase vaccination uptake: A systematic literature review of the evidence in non-United States geographies
All age groups Coverage
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Heinze, N. Martin, A. F. Tirion, A. S. C. Pae, R. Islam, J. Smith, L. E. Weston, D. Rubin, G. J.
Exploring the effectiveness of interventions to increase uptake of measles vaccination among healthcare workers: a systematic review
Healthcare workers Adolescents Adults Older adults Measles Coverage
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Abbasi, T. N. Khan, M. S. Siddiqui, E. Zaheer, M. A. Tabassum, A. Zainab, N. Waafira, A.
Exploring the safety and immunogenicity of the VLA15 vaccine among healthy or high-risk population: a systematic review and meta-analysis of randomized controlled trials
All age groups Lyme disease, Borreliosis Efficacy/effectiveness Safety Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Patel, V. Korsun, M. Cervia, J. S.
EXPRESS: Protective Effects of Booster Dose of SARS-COV-2 Vaccination Against Post-Acute COVID-19 Syndrome: A Systematic Review
Adults Older adults COVID-19 Efficacy/effectiveness Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Mirza, A. A. Almalki, A. H. Noori, F. A. Neazy, S. A. Dahm, V. Bajin, M. D. Lin, V. Y.
Facial Nerve Palsy Amid the SARS-CoV-2 Pandemic: A Pooled Analysis
All age groups COVID-19 Safety
Methodological quality (AMSTAR 2):
Low
2025 ∙ Chaudhry, T. Tum, P. Morrow, F. Hargreaves, S. Kielmann, K. Kunst, H. Griffiths, C. Campbell, N. J. C. Zenner, D.
Facilitators to strengthening vaccine uptake post-pandemic amongst underserved populations considering social norms and health beliefs: a global systematic review
Adults Older adults Parents/caregivers COVID-19 Coverage Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Rudolph, A. E. Al Akoury, N. Bogdanenko, N. Markus, K. Whittle, I. Wright, O. Haridy, H. Spinardi, J. R. McLaughlin, J. M. Kyaw, M. H.
Factors affecting the impact of COVID-19 vaccination on post COVID-19 conditions among adults: A systematic literature review
Adolescents Adults Older adults COVID-19 Efficacy/effectiveness Administration
Methodological quality (AMSTAR 2):
Low
Loading...